TickerFactsScreenerDevelopers

AYTU BIOPHARMA, INC (AYTU) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$64.8K2012: -$37.8K2017: -$13.83M2018: -$15.94M2019: -$13.83M2020: -$28.37M2021: -$25.96M2022: -$28.82M2023: -$5.13M2024: -$1.39M2025: -$1.94M-$1.94M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$1.94M-39.6%
2024-$1.39M+72.9%
2023-$5.13M+82.2%
2022-$28.82M-11.0%
2021-$25.96M+8.5%
2020-$28.37M-105.1%
2019-$13.83M+13.2%
2018-$15.94M-15.3%
2017-$13.83M—
2012-$37.8K+41.6%
2011-$64.8K—